HLYK Insider Trading Activity and SEC Form 4 Filings
HLYK insider trading summary
No open-market insider purchases or sales of HealthLynked Corp (HLYK) have been reported on SEC Form 4 in the past 12 months.
Latest HLYK insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 24, 2024 | David Rosal | Chief Financial Officer | Buy | $2K (28,333 @ $0.08) |
| Jun 20, 2024 | David Rosal | Chief Financial Officer | Buy | $3K (33,667 @ $0.08) |
| Mar 2, 2021 | Robert P. Mino | Director | Buy | $25K (50,000 @ $0.50) |
| Mar 1, 2021 | George O'Leary | Chief Financial Officer | Buy | $25K (50,000 @ $0.50) |
| Jan 13, 2021 | George O'Leary | Chief Financial Officer | Buy | $0 (100,000 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.